American Express (AXP) Offering Possible 18.2% Return Over the Next 6 Calendar Days

American Express's most recent trend suggests a bullish bias. One trading opportunity on American Express is a Bull Put Spread using a strike $99.50 short put and a strike $94.50 long put offers a potential 18.2% return on risk over the next 6 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $99.50 by expiration. The full premium credit of $0.77 would be kept by the premium seller. The risk of $4.23 would be incurred if the stock dropped below the $94.50 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for American Express is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for American Express is bullish.

The RSI indicator is at 62.15 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for American Express

Cisco, Exxon Mobil share losses lead Dow's nearly 75-point drop
Thu, 13 Aug 2020 19:23:00 +0000
DOW UPDATE Shares of Cisco and Exxon Mobil are trading lower Thursday afternoon, dragging the Dow Jones Industrial Average into negative territory. Shares of Cisco (CSCO) and Exxon Mobil (XOM) have contributed to the index's intraday decline, as the Dow (DJIA) was most recently trading 72 points (0.

QuestCap Announces Opening of Second Collection Sites, LLC Las Vegas Testing Centre
Thu, 13 Aug 2020 12:00:00 +0000
The Launch of the Second Pop-Up Lab Powered By Alcala Laboratories Doubles Daily Testing CapacityNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 13, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap”) (CSE:QSC; FRA:34C1) is pleased to announce that its portfolio company Collection Sites, LLC has opened a second pop-up testing center in Las Vegas. The draw center run is in conjunction with Alcala Testing and Analysis Services, a CLIA registered high complexity laboratory based in San Diego, California. Alcala is a recognized expert leader in rapid COVID-19 laboratory testing.The new Centre will offer antibody testing for $49/test, with the capacity for 500 tests per day. With the opening of the second location, daily testing capacity has increased to 1,000 antibody tests/day at an average price of $49. The antibody tests take 8-10 minutes to administer and return same-day certified lab results. The results can be communicated via text or email and can be accompanied with a certificate of good health via proprietary HIPAA-compliant Alcala iPhone and Android applications.The new testing center will offer convenient access to antibody testing with insurance coverage options. Appointments and payments will be handled through an online portal www.testbeforeyougo.com to limit contact points at the centers. “Collection Sites LLC is quickly implementing their strategy of opening multiple locations over the next couple weeks servicing Nevada, Arizona, Texas and Indiana offering convenient, on-site testing capability utilizing their CLIA registered partner, Alcala Labs” says Mr. Doug Sommerville, CEO of QuestCap.For more information about the pop-up lab, the available sites and services visit: www.testbeforeyougo.comAbout QuestCap Inc. QuestCap Inc. (CSE:QSC; FRA:34C1) is a social-impact investment company. It seeks, secures and funds recognized sciences, technologies, and solutions that impact our global community today.The QuestCap executive team is complemented by a panel of global advisors that provide expertise across industries and geographies. This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopedic treatment, foot and ankle care, and sports medicine.QuestCap provides financing for a diverse range of entities in exchange for pre-determined royalties or distributions, or acquires all or part of one or more businesses, portfolios or other assets.For additional information, please contact:Doug Sommerville, CEO Doug.Sommerville@Questcapinc.com 416-301-5418For US media enquiries please contact: Veronica Welch veronica@vewprmedia.com +1-508-643-8000Cautionary Note Regarding Forward-looking InformationThis press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the proposal to acquire Collection Sites LLC, the projected testing and revenue to be earned by Collection Sites LLC; the pursuit by QuestCap of investment opportunities; and the merits or potential returns of any such investments. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Dan David Shorts Dave Portnoy
Wed, 12 Aug 2020 19:14:27 +0000
The problem is that Remark Holdings' stake in Sharecare has been repossessed and is being held by the Kent County sheriff in Delaware Continue reading…

Report: American Express Close to Buying Fintech Company Kabbage
Wed, 12 Aug 2020 18:30:00 +0000
American Express (NYSE: AXP) might soon be the owner of ambitious young fintech company Kabbage. According to a report published Wednesday by Bloomberg, citing “a person familiar with the matter,” American Express is in “advanced talks” to purchase the company. The price tag could be as much as $850 million, said Bloomberg's source.

Dow Jones Surges as Boeing Reports Cancellations, IBM Signs Hybrid Cloud Deal, and American Express Eyes Kabbage
Tue, 11 Aug 2020 19:13:00 +0000
Boeing stock rebounded even as the company lost more orders, IBM was up following a hybrid cloud win, and American Express is considering an acquisition.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.